Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma

Australasian Radiology

Volumn 50, Issue 3, 2006, Pages 222-227

  Ng, M ^a,b   Wirth, A ^a   Ryan, G ^a   MacManus, M ^a   Davis, S ^a  

^a ALFRED HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Low dose radiotherapy; Low grade lymphoma; Palliative radiotherapy; Radiation therapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTOMA; MALE; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TOXICITY; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33744778165     PISSN: 00048461     EISSN: 14401673     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2006.01566.x     Document Type: Article

References (19)

1. Brittinger G Bartels H Common H et al Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas Onkologie 1986 9 : 118 25 In German A. Non-Hodgkin's lymphomas (NHL). Acta Oncol 1996 35 Suppl. 7 102 16.
2. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994 83 : 881 4.
3. Paryani SB Hoppe RT Cox RS Colby TV Kaplan HS. The role of radiation therapy in the management of stage III follicular lymphomas. J Clin Oncol 1984 2 : 841 8.
4. Verdonck LF Dekker AW Lokhorst HM Petersen EJ Nieuwenhuis HK. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood 1997 90 : 4201 5.
5. Scarantino CW Greven KM Buss DH. Single high dose-large field irradiation in drug resistant non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1988 14 : 1001 5.
6. Sutcliffe SB Gospodarowicz MK Bush RS et al. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol 1985 4 : 211 23.
7. Mac Manus MP Hoppe RT. Overview of treatment of localized low-grade lymphomas. Hematol Oncol Clin North Am 1997 11 : 901 18.
8. Mac Manus MP Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996 14 : 1282 90.
9. Johannsson J Specht L Mejer J Jensen BA. Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Int J Radiat Oncol Biol Phys 2002 54 : 1466 70.
10. Girinsky T Guillot-Vals D Koscielny S et al. A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. Int J Radiat Oncol Biol Phys 2001 51 : 148 55.
11. Sawyer EJ Timothy AR. Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma. Radiother Oncol 1997 42 : 49 51.
12. Haas RL Poortmans P de Jong D et al. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol 2003 21 : 2474 80.
13. Ganem G Lambin P Socie G et al. Potential role for low dose limited-field radiation therapy (2 × 2 Gys) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol 1994 12 : 1 8.
14. Minot G Isacc R. Lymphatic leukemia: age incidence, duration and benefit derived from irradiation. N Engl J Med 1924 191 : 1 9.
15. Carabell SC Chaffey JT Rosenthal DS Moloney WC Hellman S. Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas. Cancer 1979 43 : 994 1000.
16. Trotti A Byhardt R Stetz J et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000 47 : 13 47.
17. Horning SJ. Future directions in radioimmunotherapy for B-cell lymphoma. Semin Oncol 2003 30 : 29 34.
18. Witzig TE Gordon LI Cabanillas F et al. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol 2002 20 : 2453 63.
19. Witzig TE White CA Gordon LI et al. Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma. J Clin Oncol 2003 21 : 1263 70.